Li Zezhou, Liu Yanhua, Fu Jiaqi, Zhang Buyu, Cheng Sen, Wu Mei, Wang Zhen, Jiang Jiezhang, Chang Cheng, Liu Xiaoyun
Institute of Analytical Chemistry and Synthetic and Functional Biomolecules Center, College of Chemistry and Molecular Engineering, Peking University, Beijing, People's Republic of China.
State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Lifeomics, National Center for Protein Sciences (Beijing), Beijing, People's Republic of China.
mSystems. 2019 Apr 9;4(2). doi: 10.1128/mSystems.00314-18. eCollection 2019 Mar-Apr.
Essential to bacterial pathogenesis, Salmonella enterica serovar Typhimurium ( Typhimurium) has evolved the capacity to quickly sense and adapt to specific intracellular environment within distinct host cells. Here we examined Typhimurium proteomic remodeling within macrophages, allowing direct comparison with our previous studies in epithelial cells. In addition to many shared features, our data revealed proteomic signatures highly specific to one type of host cells. Notably, intracellular Typhimurium differentially regulates the two type III secretion systems (T3SSs) far more quickly in macrophages than in epithelial cells; bacterial flagellar and chemotaxis systems degenerate more quickly in macrophages than in HeLa cells as well. Importantly, our comparative analysis uncovered high levels of induction of bacterial histidine biosynthesis in macrophages but not in epithelial cells. Targeted metabolomic measurements revealed markedly lower histidine levels within macrophages. Intriguingly, further functional studies established that histidine biosynthesis that is defective (due to a mutation) renders the bacterium (strain SL1344) hypersensitive to intracellular shortage of this amino acid. Indeed, another Typhimurium strain, namely, strain 14028s, with a fully functional biosynthetic pathway exhibited only minor induction of the operon within infected macrophages. Our work thus provided novel insights into Typhimurium adaptation mechanisms within distinct host cells and also provided an elegant paradigm where proteomic profiling of intracellular pathogens is utilized to discriminate specific host environments (e.g., on the basis of nutrient availability). Typhimurium is one of the leading causes of foodborne bacterial infection. Nevertheless, how adapts to distinct types of host cells during infection remains poorly understood. By contrasting intracellular proteomes from both infected macrophages and epithelial cells, we found striking proteomic signatures specific to particular types of host cells. Notably, proteomic remodeling exhibited quicker kinetics in macrophages than in epithelial cells with respect to bacterial virulence and flagellar and chemotaxis systems. Furthermore, we unveiled high levels of induction of bacterial histidine biosynthesis in macrophages but not in epithelial cells, which is attributable to differing intracellular levels of this amino acid. Intriguingly, we found that a defective gene renders a strain hypersensitive to histidine shortage in macrophages. Overall, our work reveals specific adaptation mechanisms in distinct host cells, which should aid in the development of novel anti-infection strategies.
肠炎沙门氏菌鼠伤寒血清型(鼠伤寒沙门氏菌)对于细菌致病作用至关重要,它已进化出能够快速感知并适应不同宿主细胞内特定细胞内环境的能力。在此,我们研究了鼠伤寒沙门氏菌在巨噬细胞内的蛋白质组重塑情况,以便能直接与我们之前在上皮细胞中的研究进行比较。除了许多共同特征外,我们的数据还揭示了高度特异于一种宿主细胞类型的蛋白质组特征。值得注意的是,细胞内的鼠伤寒沙门氏菌在巨噬细胞中比在上皮细胞中更快地差异调节两种III型分泌系统(T3SSs);细菌鞭毛和趋化系统在巨噬细胞中比在HeLa细胞中退化得也更快。重要的是,我们的比较分析发现巨噬细胞中细菌组氨酸生物合成有高水平的诱导,而上皮细胞中则没有。靶向代谢组学测量显示巨噬细胞内组氨酸水平明显较低。有趣的是,进一步的功能研究表明,有缺陷的(由于一个突变)组氨酸生物合成使细菌(菌株SL1344)对这种氨基酸的细胞内短缺高度敏感。事实上,另一种鼠伤寒沙门氏菌菌株,即14028s菌株,具有完全功能的生物合成途径,在感染的巨噬细胞内仅表现出该操纵子的轻微诱导。因此,我们的工作为鼠伤寒沙门氏菌在不同宿主细胞内的适应机制提供了新的见解,也提供了一个优雅的范例,即利用细胞内病原体的蛋白质组分析来区分特定的宿主环境(例如,基于营养可用性)。鼠伤寒沙门氏菌是食源性细菌感染的主要原因之一。然而,在感染期间它如何适应不同类型的宿主细胞仍知之甚少。通过对比感染的巨噬细胞和上皮细胞内的鼠伤寒沙门氏菌蛋白质组,我们发现了特定于特定类型宿主细胞的显著蛋白质组特征。值得注意的是,就细菌毒力以及鞭毛和趋化系统而言,鼠伤寒沙门氏菌的蛋白质组重塑在巨噬细胞中比在上皮细胞中表现出更快的动力学。此外,我们发现巨噬细胞中细菌组氨酸生物合成有高水平的诱导,而上皮细胞中则没有,这归因于这种氨基酸在细胞内的不同水平。有趣的是,我们发现一个有缺陷的基因使鼠伤寒沙门氏菌菌株对巨噬细胞内组氨酸短缺高度敏感。总体而言,我们的工作揭示了在不同宿主细胞中的特定适应机制,这应该有助于开发新的抗感染策略。